New (poly)aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, a process for preparing them, and application thereof in therapy as anticancer agents

Details for Australian Patent Application No. 2009284086 (hide)

Owner Pierre Fabre Medicament

Inventors Imbert, Thierry; Guminski, Yves; Barret, Jean-Marc; Kruczynski, Anna

Agent Freehills

Pub. Number AU-A-2009284086

PCT Pub. Number WO2010/020663

Priority 0855629 19.08.08 FR

Filing date 19 August 2009

Wipo publication date 25 February 2010

International Classifications

C07D 493/04 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

A61K 31/36 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

17 February 2011 PCT application entered the National Phase

  PCT publication WO2010/020663 Priority application(s): WO2010/020663

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009284092-Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE)

2009284080-High rate stimulation method for deep, large bore completions